HCA Healthcare, Inc. - Q1 2006 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2006. HCA Inc. is a holding company whose affiliates own and operate 176 hospitals and 91 freestanding surgery centers across 21 U.S. states, England, and Switzerland. The company operates in a single line of business: operating hospitals and related health care entities. Approximately 28% of patient revenues are derived from Medicare participants.
Key Financial Metrics
| Metric | Q1 2006 | Q1 2005 |
|---|---|---|
| Revenues | $6,415 million | $6,182 million |
| Net Income | $379 million | $414 million |
| Diluted EPS | $0.92 | $0.95 |
| Operating Cash Flow | $365 million | $852 million |
| Long-Term Debt | $10,608 million | $9,889 million (Dec 2005) |
| Cash and Equivalents | $453 million | $336 million (Dec 2005) |
| Adjusted Segment EBITDA | $1,193 million | $1,204 million |
Note: Operating cash flow decreased significantly due to higher tax payments ($275 million net paid in Q1 2006 vs. $85 million net refund in Q1 2005) and increased working capital payments.
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 3.8% year-over-year, driven by a 5.5% increase in revenue per equivalent admission, partially offset by a 1.6% decrease in equivalent admissions.
- Profitability Decline: Net income decreased 8.5% to $379 million. This decline was influenced by increased interest expense ($186 million vs. $164 million) and the adoption of new accounting standards for share-based compensation.
- Uninsured Discounts: The company recorded $256 million in discounts for uninsured patients in Q1 2006, compared to $109 million in Q1 2005. Adjusting for these discounts, the provision for doubtful accounts rose to 12.8% of revenues from 10.9%.
- Investment Gains: Gains on investments from the insurance subsidiary increased significantly to $75 million from $9 million in the prior year.
- Share Repurchases: The company completed a $2.5 billion share repurchase authorization, buying back 13.0 million shares for $651 million in Q1 2006.
Guidance, Outlook, and Risks
- Capital Expenditures: Management expects capital expenditures to approximate $1.9 billion for 2006. Projects under construction have estimated additional costs of $3.1 billion over the next five years.
- Accounting Changes: Effective January 1, 2006, the company adopted SFAS 123(R) for share-based compensation, resulting in an $8 million reduction in pre-tax income for the quarter.
- Legal and Regulatory Risks:
- IRS Disputes: The IRS is seeking an additional $579 million in taxes, interest, and penalties regarding returns from 1990–2002. Management believes provisions are adequate.
- Government Investigations: The company is cooperating with a formal SEC investigation and a subpoena from the U.S. Attorney for the Southern District of New York regarding trading in HCA securities.
- Securities Litigation: Multiple class action and derivative lawsuits were filed in late 2005 regarding Q2 2005 preliminary results; these are currently consolidated and stayed pending motions to dismiss.
- Operational Risks: Significant exposure to hurricanes in Florida and Texas (74 hospitals located in these states) and potential increases in insurance premiums and deductibles. Additionally, changes in Medicare/Medicaid reimbursement rates pose a risk to future revenues.
Investor Verification Checklist
- Uninsured Discount Impact: Verify the sustainability of the 12.8% provision for doubtful accounts (adjusted for uninsured discounts) and its effect on future margins.
- IRS Dispute Resolution: Monitor the status of the $579 million IRS claim and the adequacy of current tax reserves.
- Legal Proceedings: Track the outcome of the SEC investigation and the consolidated securities class action lawsuits.
- Debt Servicing: Assess the impact of rising interest rates (average rate increased to 7.1%) on future interest expense given the $11.3 billion debt load.
- Share Repurchase Completion: Confirm the full utilization of the $2.5 billion buyback authorization and its impact on diluted share count.